Literature DB >> 11176654

Imiquimod and 5% fluorouracil therapy for anal and perianal squamous cell carcinoma in situ in an HIV-1-positive man.

J Pehoushek1, K J Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11176654     DOI： 10.1001/archderm.137.1.14

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  8 in total

1.  Nonsurgical innovations in the treatment of nonmelanoma skin cancer.

Authors:  Sadegh Amini; Martha H Viera; Whitney Valins; Brian Berman
Journal:  J Clin Aesthet Dermatol       Date:  2010-06

Review 2.  The role of topical immune response modifiers in skin cancer.

Authors:  Courtney Woodmansee; Jessica Pillow; Robert B Skinner
Journal:  Drugs       Date:  2006       Impact factor: 9.546

3.  Initial Development and Content Validation of a Health-Related Symptom Index for Persons either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions.

Authors:  Jack E Burkhalter; Thomas M Atkinson; J Berry-Lawhorn; Stephen Goldstone; Mark H Einstein; Timothy J Wilkin; Jeannette Lee; David Cella; Joel M Palefsky
Journal:  Value Health       Date:  2018-04-11       Impact factor: 5.725

4.  A trial of radiofrequency ablation for anal intraepithelial neoplasia.

Authors:  Robert N Goldstone; Shirin R Hasan; Steven Drury; Teresa M Darragh; Annemieke van Zante; Stephen E Goldstone
Journal:  Int J Colorectal Dis       Date:  2016-10-21       Impact factor: 2.571

5.  Clinical results of infrared coagulation as a treatment of high-grade anal dysplasia: a systematic review.

Authors:  J Corral; D Parés; F García-Cuyás; B Revollo; S Videla; A Chamorro; M Piñol; B Clotet; G Sirera
Journal:  Tech Coloproctol       Date:  2019-07-23       Impact factor: 3.781

Review 6.  Anal intraepithelial neoplasia in HIV positive people.

Authors:  F Martin; M Bower
Journal:  Sex Transm Infect       Date:  2001-10       Impact factor: 3.519

7.  Malignant conversion of florid oral and labial papillomatosis during topical immunotherapy with imiquimod.

Authors:  K Wenzel; B Saka; R Zimmermann; K K H Gundlach; M Barten; G Gross
Journal:  Med Microbiol Immunol       Date:  2003-04-29       Impact factor: 3.402

8.  Bowen's disease - a review of newer treatment options.

Authors:  Thorsten Neubert; Percy Lehmann
Journal:  Ther Clin Risk Manag       Date:  2008-10       Impact factor: 2.423
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.